Kyber Data Science Announces $10 Million Series A Financing Round
Kyber is focused on developing and selling unique and proprietary datasets across a variety of sectors to institutional investors and corporations. Most recently, Kyber unveiled a nationally-representative health care claims and electronic medical records data product for the institutional investor that enables timely and accurate analyses across health care subsectors including drug, medical device, diagnostics, and facilities companies. Transaction-level data allow customers to develop a large number of key performance indicators, and drive granular insights into the intricacies of product revenue and disease dynamics.
"At Cowen, we are constantly striving to help clients outperform and to build systems and services that are deeply entrenched within the DNA of the sectors that we serve,” said
“Kyber was established on the belief that data is a tool for alpha generation versus data as a strategy unto itself,” said Robert Fagin, Kyber’s Executive Chair. “As we have continued to grow our product sets, we are extremely pleased to elevate our operation through outside capital and the participation of
"I have had a passion for health care from the time I walked rounds in the hospital with my grandfather, who was a surgeon. Life sciences has always been a core focus of my investment activities, so it only seems fitting to partner with Cowen in helping to create Kyber, as Cowen now boasts one of the leading health care platforms on the Street,” said
About Cowen Inc.
Cowen is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen focuses on delivering value-added capabilities to our clients in order to help them outperform. Founded in 1918, the Company is headquartered in New York and has offices worldwide. Learn more at Cowen.com.
Source: Cowen Inc.